Melissa Larson

8PUBLICATIONS
93CO-AUTHORS
Disease surveillanceMolecular targetsLiquid biopsiesReproductionHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 24, 2026
No association of prior administration of selected vaccines with lymphoma prognosis.

|Jan 14, 2026
Dual FAK and EPHA2 targeting by brigatinib tackles PARP inhibitor adaptive survival response in high-grade serous ovarian cancer.

Julie R Duffield, Xiaonan Hou, Benjamin W Wilson

|Dec 02, 2025
FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma.

Matthew J Maurer, Vit K Prochazka, Tarec Christoffer El-Galaly

|Nov 03, 2025
Occurrence and predictors of patient reported fertility discussions in non-Hodgkin lymphoma patients: utilizing the lymphoma epidemiology of outcomes (LEO) cohort study.

Nadia Toumeh, Melissa Larson, Brianna Negaard

|Mar 06, 2025
Evaluation of Etiologic Heterogeneity for Risk of Diffuse Large B-Cell Lymphoma Subtype Defined by the Cell of Origin.

Geffen Kleinstern, Dennis P Robinson, Lisa M Rimsza

|Feb 07, 2025
Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With R-GemOx: A Multicenter Cohort Study.

Samuel Yamshon, Jean L Koff, Melissa C Larson

Pageof 2

Frequent Collaborators

7 joint publications

Matthew Maurer

6 joint publications

Thomas M Habermann

5 joint publications

James R Cerhan

4 joint publications

Andrew L Feldman